Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |